Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,171) with videos related to
Page
of 118
Sort By:
Platelets
|
March 5, 2020
Lymphatic blood filling in CLEC-2-deficient mouse models
Elizabeth J Haining, Kate L Lowe, Surasak Wichaiyo, et al.
ACS Medicinal Chemistry Letters
|
November 17, 2022
Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding Mode
Stacey M Southall, Joydeep Banerjee, Jason Brown, et al.
Blood Cancer Journal
|
August 16, 2014
A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
J F Seymour, D W Kim, E Rubin, et al.
The Journal of Biological Chemistry
|
November 5, 2014
Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells
Alice Y Pollitt, Natalie S Poulter, Eelo Gitz, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists
Gillian E Lunniss, Ashley A Barnes, Nick Barton, et al.
Nature Communications
|
April 24, 2020
The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure
Abhishek Chauhan, Lozan Sheriff, Mohammed T Hussain, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 18, 2006
Identification of novel pyrazole acid antagonists for the EP1 receptor
Stephen C McKeown, Adrian Hall, Gerard M P Giblin, et al.
British Journal of Haematology
|
November 17, 2006
A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO
Paula H B Bolton-Maggs, Elizabeth A Chalmers, Peter W Collins, et al.
Science Signaling
|
November 1, 2012
Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function
Alexandra Mazharian, Ying-Jie Wang, Jun Mori, et al.
Leukemia
|
July 10, 2012
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
F J Giles, R T Swords, A Nagler, et al.
Page
of 118
Search research articles
Search
Showing results (1091-1100 of 1,171) with videos related to
Sort By:
Page
of 118
Platelets
|
March 5, 2020
Lymphatic blood filling in CLEC-2-deficient mouse models
Elizabeth J Haining, Kate L Lowe, Surasak Wichaiyo, et al.
ACS Medicinal Chemistry Letters
|
November 17, 2022
Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding Mode
Stacey M Southall, Joydeep Banerjee, Jason Brown, et al.
Blood Cancer Journal
|
August 16, 2014
A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
J F Seymour, D W Kim, E Rubin, et al.
The Journal of Biological Chemistry
|
November 5, 2014
Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells
Alice Y Pollitt, Natalie S Poulter, Eelo Gitz, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists
Gillian E Lunniss, Ashley A Barnes, Nick Barton, et al.
Nature Communications
|
April 24, 2020
The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure
Abhishek Chauhan, Lozan Sheriff, Mohammed T Hussain, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 18, 2006
Identification of novel pyrazole acid antagonists for the EP1 receptor
Stephen C McKeown, Adrian Hall, Gerard M P Giblin, et al.
British Journal of Haematology
|
November 17, 2006
A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO
Paula H B Bolton-Maggs, Elizabeth A Chalmers, Peter W Collins, et al.
Science Signaling
|
November 1, 2012
Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function
Alexandra Mazharian, Ying-Jie Wang, Jun Mori, et al.
Leukemia
|
July 10, 2012
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
F J Giles, R T Swords, A Nagler, et al.
Page
of 118